MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.vaccine.2014.01.011

Медицинская библиотека · Vaccine · 2014

Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine.

Tani Chiara, Stella Maria, Donnarumma Danilo, Biagini Massimiliano, Parente Pierino, Vadi Alessandro, Magagnoli Claudia, Costantino Paolo, Rigat Fabio, Norais Nathalie

СтатьяПеревод в очереди

Аннотация

Meningococcal disease is a major cause of morbidity and mortality worldwide. Its epidemiology is currently dominated by five capsular serogroups (A, B, C, W, and Y). While effective vaccines already exist for serogroups A, C, W and Y, except for under clonal outbreaks, no vaccine was available against serogroup B. Recently, a four component vaccine, Bexsero(®), designed to prevent infection caused by this serogroup, has been approved in Europe and other Countries for use in individuals from two months of age and older. The active components of this vaccine are three recombinant proteins identified by reverse vaccinology combined with detergent extracted outer membrane vesicles (DOMV) prepared from a New Zealand epidemic strain. Considering their intrinsic complexity, we performed additional characterization of DOMVs on top of the standard quality control testing carried out for batch release. We applied the Hi3 label-free LC-MS(E) methodology to qualitatively and quantitatively characterize the DOMV protein content. We first, successfully investigated the robustness and the accuracy of the methodology for the DOMV characterization and we then applied it to compare six DOMV production lots. Around 100 proteins were quantified from each preparation. When classified according to their predicted cellular localization, about 90% of the total protein amount belongs consistently to the outer membrane compartment. Using nonparametric hypothesis testing and complementary log-log linear regression, the quantifications of a subset of 21 proteins common to all lots and including approximately 90% (85-92%) of the total protein amount quantified in any DOMV lot were found consistent across lots. The relevance of these results is two-fold, showing that the Hi3 quantification methodology is robust for a broad range of proteins and indicating that the manufacturing process currently used for the production of the Bexsero(®) DOMV components is highly reproducible and consistent.

Для цитирования: Tani Chiara, Stella Maria, Donnarumma Danilo, Biagini Massimiliano, Parente Pierino, Vadi Alessandro, Magagnoli Claudia, Costantino Paolo, Rigat Fabio, Norais Nathalie. Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine.. Vaccine. 2014. DOI: 10.1016/j.vaccine.2014.01.011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.